Search research articles
Contact Us
Filters
Showing results (11-20 of 50) with videos related to
Page
of 5
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
May 3, 2025
Approach to the Patient with Metastatic Pheochromocytoma and Paraganglioma
Hussam Alkaissi, David Taieb, Frank I Lin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 31, 2021
Imaging of Pheochromocytoma and Paraganglioma
Jorge A Carrasquillo, Clara C Chen, Abhishek Jha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 29, 2013
Preclinical efficacy of the anti-hepatocyte growth factor antibody ficlatuzumab in a mouse brain orthotopic glioma model evaluated by bioluminescence, PET, and MRI
Erik S Mittra, Hua Fan-Minogue, Frank I Lin, et al.
Nature Reviews. Urology
|
October 14, 2025
Therapeutic targeting of prostate-specific membrane antigen could limit its potential as benchmark imaging
Melissa L Abel, Adam Sharp, Edwin M Posadas, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 9, 2011
Prospective comparison of combined 18F-FDG and 18F-NaF PET/CT vs. 18F-FDG PET/CT imaging for detection of malignancy
Frank I Lin, Jyotsna E Rao, Erik S Mittra, et al.
Communications Engineering
|
May 15, 2025
A Quantitative Particle Identification (QPID) spectral autoradiography system
Stephen S Adler, Noriko Sato, Kwamena E Baidoo, et al.
Science Translational Medicine
|
April 22, 2011
The fate and toxicity of Raman-active silica-gold nanoparticles in mice
Avnesh S Thakor, Richard Luong, Ramasamy Paulmurugan, et al.
Frontiers in Oncology
|
May 8, 2024
Salivary excretion of systemically injected [<sup>18</sup>F]DCFPyL in prostate cancer patients undergoing PSMA scans
Bruna Fernandes, Jyoti Roy, Falguni Basuli, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 6, 2025
Safety, Dosimetry, and Feasibility of [<sup>68</sup>Ga]Ga-PSMA-R2 as an Imaging Agent in Patients with Biochemical Recurrence or Metastatic Prostate Cancer
Liza Lindenberg, Thomas A Hope, Frank I Lin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 15, 2025
Unraveling the dynamics of B7-H3-targeting therapeutic antibodies in cancer through PET imaging and antibody pharmacokinetics
Bruna Fernandes, Colleen P Olkowski, Behnaz Ghaemi, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 50) with videos related to
Sort By:
Page
of 5
The Journal of Clinical Endocrinology and Metabolism
|
May 3, 2025
Approach to the Patient with Metastatic Pheochromocytoma and Paraganglioma
Hussam Alkaissi, David Taieb, Frank I Lin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 31, 2021
Imaging of Pheochromocytoma and Paraganglioma
Jorge A Carrasquillo, Clara C Chen, Abhishek Jha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 29, 2013
Preclinical efficacy of the anti-hepatocyte growth factor antibody ficlatuzumab in a mouse brain orthotopic glioma model evaluated by bioluminescence, PET, and MRI
Erik S Mittra, Hua Fan-Minogue, Frank I Lin, et al.
Nature Reviews. Urology
|
October 14, 2025
Therapeutic targeting of prostate-specific membrane antigen could limit its potential as benchmark imaging
Melissa L Abel, Adam Sharp, Edwin M Posadas, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 9, 2011
Prospective comparison of combined 18F-FDG and 18F-NaF PET/CT vs. 18F-FDG PET/CT imaging for detection of malignancy
Frank I Lin, Jyotsna E Rao, Erik S Mittra, et al.
Communications Engineering
|
May 15, 2025
A Quantitative Particle Identification (QPID) spectral autoradiography system
Stephen S Adler, Noriko Sato, Kwamena E Baidoo, et al.
Science Translational Medicine
|
April 22, 2011
The fate and toxicity of Raman-active silica-gold nanoparticles in mice
Avnesh S Thakor, Richard Luong, Ramasamy Paulmurugan, et al.
Frontiers in Oncology
|
May 8, 2024
Salivary excretion of systemically injected [<sup>18</sup>F]DCFPyL in prostate cancer patients undergoing PSMA scans
Bruna Fernandes, Jyoti Roy, Falguni Basuli, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 6, 2025
Safety, Dosimetry, and Feasibility of [<sup>68</sup>Ga]Ga-PSMA-R2 as an Imaging Agent in Patients with Biochemical Recurrence or Metastatic Prostate Cancer
Liza Lindenberg, Thomas A Hope, Frank I Lin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 15, 2025
Unraveling the dynamics of B7-H3-targeting therapeutic antibodies in cancer through PET imaging and antibody pharmacokinetics
Bruna Fernandes, Colleen P Olkowski, Behnaz Ghaemi, et al.
Page
of 5